Literature DB >> 2381451

Ciprofloxacin in a case of Q fever endocarditis.

M Yebra, J Ortigosa, F Albarrán, M G Crespo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2381451     DOI： 10.1056/NEJM199008303230917

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Q fever in Quebec (1989-93): Report of 14 cases.

Authors:  M Goyette; A Poirier; J Bouchard; E Morrier
Journal:  Can J Infect Dis       Date:  1994-05

2.  Shell-vial assay: evaluation of a new technique for determining antibiotic susceptibility, tested in 13 isolates of Coxiella burnetii.

Authors:  D Raoult; H Torres; M Drancourt
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

3.  Mechanisms that may account for differential antibiotic susceptibilities among Coxiella burnetii isolates.

Authors:  M R Yeaman; O G Baca
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

4.  A case of Q fever endocarditis treated medically: 9 years of follow-up.

Authors:  D Dalmau; J Castãné; E Alvarez; L Ortega; J Garau
Journal:  Infection       Date:  1997 Mar-Apr       Impact factor: 3.553

5.  Efficacy of liposome-encapsulated ciprofloxacin in a murine model of Q fever.

Authors:  I H Norville; G J Hatch; K R Bewley; D J Atkinson; K A Hamblin; J D Blanchard; S J Armstrong; J K Pitman; E Rayner; G Hall; J Vipond; T P Atkins
Journal:  Antimicrob Agents Chemother       Date:  2014-07-07       Impact factor: 5.191

6.  Finafloxacin, a Novel Fluoroquinolone, Reduces the Clinical Signs of Infection and Pathology in a Mouse Model of Q Fever.

Authors:  M Gill Hartley; Isobel H Norville; Mark I Richards; Kay B Barnes; Kevin R Bewley; Julia Vipond; Emma Rayner; Andreas Vente; Stuart J Armstrong; Sarah V Harding
Journal:  Front Microbiol       Date:  2021-11-30       Impact factor: 5.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.